世界の肺炎治療薬市場は、2021年に約132億4,000万米ドルと評価され、予測期間の2022年から2029年には8.5%を超える健全な成長率で成長すると予想されています。肺炎は、細菌、ウイルス、真菌によって引き起こされる片肺または両肺の気嚢に炎症を起こす急性呼吸器感染症の一種です。肺炎の症状には、緑色や黄色、血の混じった粘液を伴う咳、発熱、発汗、息切れ、急速で浅い呼吸、刺すような胸痛などが含まれます。肺炎の発生件数の増加やアンメットニーズの高まり、また大手企業による戦略的な取り組みが、市場の成長を加速させる主な要因となっています。
ユニセフによると、2019年現在、世界では毎年約70万人の5歳未満児が命を落とし、毎日約2,000人が亡くなっているとのことです。また、南アジア（子ども10万人あたり2,500件）が最も影響を受けている地域であり、西・中央アフリカ（子ども10万人あたり1,620件）がそれに続いています。また、新興国における医療費の増加や医薬品分野の研究開発活動の活発化により、予測期間中に市場が大きく成長することが見込まれています。しかし、高い治療費と予防ワクチンに対する認識不足が、2022年から2029年の予測期間を通じて市場成長の妨げとなります。
世界の肺炎治療薬市場の調査において考慮された主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、世界のその他の地域です。北アメリカは、大手製薬企業の存在と、同地域における強固なヘルスケアインフラの利用可能性から、収益の面で主要な地域となっています。一方、アジア太平洋地域は、高齢者人口の増加や小児肺炎の増加などの要因から、予測期間中に大きく成長すると予想されています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pneumonia Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pneumonia Therapeutics Market Dynamics
3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Pneumonia
3.1.1.2. Growing unmet clinical needs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost.
3.1.2.2. Lack of awareness towards preventive vaccines.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare spending in developing regions.
3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.
Chapter 4. Global Pneumonia Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pneumonia Therapeutics Market, by Therapeutics
6.1. Market Snapshot
6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
6.4.1. Prevention Vaccines
6.4.2. Treatment Drugs
Chapter 7. Global Pneumonia Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceutical Stores
7.4.3. Others
Chapter 8. Global Pneumonia Therapeutics Market, by Age Group
8.1. Market Snapshot
8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
8.4.1. Pediatric
8.4.2. Adult
8.4.3. Geriatric
Chapter 9. Global Pneumonia Therapeutics Market, Regional Analysis
9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
9.2. North America Pneumonia Therapeutics Market
9.2.1. U.S. Pneumonia Therapeutics Market
9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pneumonia Therapeutics Market
9.3. Europe Pneumonia Therapeutics Market Snapshot
9.3.1. U.K. Pneumonia Therapeutics Market
9.3.2. Germany Pneumonia Therapeutics Market
9.3.3. France Pneumonia Therapeutics Market
9.3.4. Spain Pneumonia Therapeutics Market
9.3.5. Italy Pneumonia Therapeutics Market
9.3.6. Rest of Europe Pneumonia Therapeutics Market
9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
9.4.1. China Pneumonia Therapeutics Market
9.4.2. India Pneumonia Therapeutics Market
9.4.3. Japan Pneumonia Therapeutics Market
9.4.4. Australia Pneumonia Therapeutics Market
9.4.5. South Korea Pneumonia Therapeutics Market
9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
9.5. Latin America Pneumonia Therapeutics Market Snapshot
9.5.1. Brazil Pneumonia Therapeutics Market
9.5.2. Mexico Pneumonia Therapeutics Market
9.6. Rest of The World Pneumonia Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Eli Lilly & Company
10.2.4. GlaxoSmithKline PLC.
10.2.5. Lupin Pharmaceuticals, Inc.
10.2.6. Merck KGAA
10.2.7. Novartis AG
10.2.8. Pfizer, Inc.
10.2.9. Sanofi S.A.
10.2.10. Teva Pharmaceuticals Industries Limited.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Pneumonia Therapeutics Market, report scope
TABLE 2. Global Pneumonia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pneumonia Therapeutics Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
TABLE 4. Global Pneumonia Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Pneumonia Therapeutics Market estimates & forecasts by Age Group 2019-2029 (USD Billion)
TABLE 6. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Pneumonia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Pneumonia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pneumonia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Pneumonia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Pneumonia Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Pneumonia Therapeutics Market, research methodology
FIG 2. Global Pneumonia Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pneumonia Therapeutics Market, key trends 2021
FIG 5. Global Pneumonia Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Pneumonia Therapeutics Market, porters 5 force model
FIG 7. Global Pneumonia Therapeutics Market, pest analysis
FIG 8. Global Pneumonia Therapeutics Market, value chain analysis
FIG 9. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Pneumonia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Pneumonia Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Pneumonia Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Pneumonia Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
